Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis

[1]  A. Ghaemmaghami,et al.  Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins , 2010, Proceedings of the National Academy of Sciences.

[2]  A. Rosenwald,et al.  Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations , 2010, Haematologica.

[3]  J. Imbert,et al.  Peripheral T‐cell lymphoma gene expression profiling and potential therapeutic exploitations , 2010, British journal of haematology.

[4]  J. Holch,et al.  The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma , 2010, The Journal of experimental medicine.

[5]  Dan M. Jones.  Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection. , 2010, Seminars in hematology.

[6]  M. Piris,et al.  Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma , 2010, Haematologica.

[7]  W. Chan,et al.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.

[8]  Edu,et al.  T-cell Activation Promotes Tumorigenesis in Inflammation-associated Cancer Recommended Citation Retrovirology T-cell Activation Promotes Tumorigenesis in Inflammation-associated Cancer , 2022 .

[9]  H. Ikeda,et al.  Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. , 2009, Cancer research.

[10]  Jie Jin,et al.  Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China , 2009, International journal of hematology.

[11]  H. Fujiwara,et al.  Aurora-A kinase: a novel target of cellular immunotherapy for leukemia. , 2008, Blood.

[12]  J. Grutters,et al.  Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. , 2008, Chest.

[13]  T. Haydar,et al.  Protein Kinase C δ Localizes to Secretory Lysosomes in CD8+ CTL and Directly Mediates TCR Signals Leading to Granule Exocytosis-Mediated Cytotoxicity1 , 2008, The Journal of Immunology.

[14]  D. Weisenburger,et al.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Jian Huang,et al.  Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome , 2008, Leukemia & lymphoma.

[16]  Keunchil Park,et al.  Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified” , 2008, Annals of Hematology.

[17]  M. Teitell,et al.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. , 2008, Blood.

[18]  I. Su,et al.  Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein–Barr virus‐associated T‐cell lymphoma: Nuclear factor‐κB pathway as a potential therapeutic target , 2007, Cancer science.

[19]  N. Takeyama,et al.  Selective expansion of the CD14+/CD16bright subpopulation of circulating monocytes in patients with hemophagocytic syndrome , 2007, Annals of Hematology.

[20]  K. Savage.  Peripheral T-cell lymphomas. , 2007, Blood reviews.

[21]  S. Chuang,et al.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. , 2007, The American journal of pathology.

[22]  Stefano A Pileri,et al.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. , 2007, The Journal of clinical investigation.

[23]  S. Chuang,et al.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. , 2007, The American journal of pathology.

[24]  Patrice Duroux,et al.  IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences , 2005, Nucleic Acids Res..

[25]  A. Frey,et al.  T-cell receptor signaling events triggering granule exocytosis. , 2006, Critical reviews in immunology.

[26]  E. Iannitto,et al.  Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. , 2004, Blood.

[27]  Takayuki Takahashi,et al.  The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas , 2003, International journal of hematology.

[28]  L. Davis,et al.  Expansion of activated human naïve T‐cells precedes effector function , 2002, Clinical and experimental immunology.

[29]  Y. Yamashita,et al.  Nodal CD8 Positive Cytotoxic T-Cell Lymphoma: A Distinct Clinicopathological Entity , 2002, Modern Pathology.

[30]  M. Freedman,et al.  Establishment of a Cytokine-Producing Anaplastic Large-Cell Lymphoma Cell Line Containing the t(2;5) Translocation: Potential Role of Cytokines in Clinical Manifestations , 2001, Leukemia & lymphoma.

[31]  S. Fujita,et al.  Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.

[32]  S. Fujita,et al.  HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. , 2000, Blood.

[33]  J. Hansen,et al.  Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition. , 1999, Tissue antigens.

[34]  P. Gaulard,et al.  Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T‐cell lymphomas , 1997 .

[35]  T. Habermann,et al.  Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  T. Horiuchi,et al.  Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells. , 1991, Journal of immunology.

[37]  S. Pileri,et al.  Peripheral T-cell lymphoma associated with hemophagocytic syndrome. , 1990, Blood.

[38]  Michall Vladimirovich Sitkovsk.  Mechanistic, Functional and Immunopharmacological Implications of Biochemical Studies of Antigen Receptor‐Triggered Cytolytic T‐Lymphocyte Activation * , 1988 .

[39]  M. Sitkovsky.  Mechanistic, functional and immunopharmacological implications of biochemical studies of antigen receptor-triggered cytolytic T-lymphocyte activation. , 1988, Immunological reviews.

[40]  Z. Ballas,et al.  Studies on the mechanism of lymphocyte-mediated cytolysis. XI. The role of lectin in lectin-dependent cell-mediated cytotoxicity. , 1978, Journal of immunology.